{"transactions":[{"id":3865303,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":164942,"kind":"person","name":"Dupret Daniel","position":1,"cik":"0001680916","reported_name":"Dupret Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Options","published_at":"2018-07-18T15:57:46.000Z","date":"2018-07-12","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options with respect to 30,000 shares vest upon the acceptance of a U.S. IND for MS 1819, and the remaining 30,000 shares vest upon the the first CF patient dosed with MS1819 anywhere in the globe."}],"balance_after":60000,"derivative":{"exercise_price":3.04,"expiration_date":"2023-06-28","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001415889-18-001122","document":"form4-07182018_080729.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000141588918001122/form4-07182018_080729.xml","form_type":"4"}},{"id":3865302,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":164942,"kind":"person","name":"Dupret Daniel","position":1,"cik":"0001680916","reported_name":"Dupret Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2018-07-18T15:57:46.000Z","date":"2018-07-12","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents grant of restricted stock. Shares shall vest in increments as follows: 7,500 shares upon the acceptance of a U.S. IND for MS1819, and 7,500 shares upon the the first CF patient dosed with MS1819 anywhere in the globe."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001415889-18-001122","document":"form4-07182018_080729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000141588918001122/form4-07182018_080729.xml","form_type":"4"}}]}